Dr William Schilling
Contact information
Research groups
William Schilling
Research Physician
Will is a research physician working at the Mahidol Oxford Tropical Medicine Research Unit (MORU), a specialty registrar in Infectious diseases and Microbiology in the UK. He is a DPhil student at the University of Oxford.
Will has been working at MORU since August 2019 and had focussed on research into community febrile illness. Since January 2020 and the appearance of COVID-19, he has turned his attention to potential therapies which may prevent infection with COVID-19, including two widely available drugs, chloroquine and hydroxychloroquine, that demonstrated promising in vitro effects against SARS-CoV-2. At the time of writing, the COVID-19 pandemic is worsening and there are no prophylactic agents nor vaccines or proven-effective treatments available. The aim is to rapidly determine if these, and other drugs, can be used as prophylactic agents against COVID-19.
Will has previous experience working in Medicine in Mbarara, Uganda.
Recent publications
-
Antimicrobial resistance patterns in bacteria causing febrile illness in Africa, South Asia, and Southeast Asia: a systematic review of published etiological studies from 1980-2015
Roberts T. et al, (2022), International Journal of Infectious Diseases, 122, 612 - 621
-
Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study
Perrone C. et al, (2022)
-
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project
Chandna A. et al, (2022), Wellcome Open Research, 6, 64 - 64
-
The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions
Schilling WHK. et al, (2021), Wellcome Open Research, 6, 71 - 71
-
Good participatory practice for coronavirus disease 2019 (COVID-19) research: the case of a COVID-19 prevention study
Perrone C. et al, (2021), Wellcome Open Research, 6, 216 - 216